Zvinetso zvakawanda zvehutachiona hwekufema munguva yechando
Matanho ekuderedza kutapurirana kweSARS-CoV-2 avewo achishanda mukuderedza kutapurirana kwemamwe mavhairasi ekufema emunzvimbo iyi. Sezvo nyika zhinji dzichideredza kushandiswa kwematanho akadaro, SARS-CoV-2 ichapararira nemamwe mavhairasi ekufema, zvichiwedzera mukana wekutapurirana pamwe chete.
Nyanzvi dzinofanotaura kuti panogona kunge paine denda remavhairasi katatu munguva yechando ino nekuda kwekusanganiswa kwemwaka wepamusoro wefuruwenza (Flu) nehutachiona hwekufema (RSV) nedenda reSARS-CoV-2 virus. Huwandu hwevanhu vane furuwenza neRSV gore rino hwatove hwakakwira kupfuura hwenguva imwe chete mumakore apfuura. Mhando itsva dzeBA.4 neBA.5 dzehutachiona hweSARS-CoV-2 dzakawedzera denda zvakare.
Pamusangano we "World Flu 2022 Symposium" musi wa1 Mbudzi 2022, Zhong Nanshan, nyanzvi yeChinese Academy of Engineering, akaongorora zvizere mamiriro efuruwenza munyika nekunze kwenyika, uye akaita tsvakiridzo yazvino uye kutonga pamusoro pemamiriro aripo iye zvino."Nyika ichiri kutarisana nenjodzi yezvirwere zveSARS-CoV-2 virus uye furuwenza." Akataura kuti, "Kunyanya munguva yechando ino, ichiri kuda kusimbisa tsvakiridzo panyaya dzesainzi dzekudzivirira nekudzora furuwenza."Zvichienderana nenhamba dzeUS CDC, huwandu hwevanhu vanoshanyira zvipatara nekuda kwezvirwere zvekufema muUnited States hwakawedzera zvakanyanya nekuda kwekusanganiswa kwefuruwenza nezvirwere zvitsva zvemoyo.
Kuwedzera kwekuonekwa kwevarwere vane RSV uye kushanya kwevashandi vekurapa vane RSV pamwe nekuiswa muzvipatara munzvimbo dzakasiyana dzeUS, nedzimwe nzvimbo dziri pedyo nemwaka. Parizvino, huwandu hwevanhu vane chirwere cheRSV muUS hwasvika padanho repamusoro mumakore makumi maviri nemashanu, zvichiita kuti zvipatara zvevana zviwande, uye zvimwe zvikoro zvakavharwa.
Denda refuruwenza rakatanga muAustralia muna Kubvumbi gore rino uye rakagara kwemwedzi inoda kusvika mina. Kubva musi wa25 Gunyana, paive nevanhu 224,565 vakaongororwa murabhoritari, zvikaita kuti pave nerufu rwakabatana nevanhu 305. Kusiyana neizvi, pasi pematanho ekudzivirira denda reSARS-CoV-2, pachava nevanhu vanosvika 21,000 vane furuwenza muAustralia muna 2020 uye vashoma pane 1,000 muna 2021.
Mushumo wevhiki rechi35 weChina Influenza Center muna 2022 unoratidza kuti huwandu hwevanhu vane furuwenza mumatunhu ekuchamhembe hwave hwakakwira kupfuura huwandu hwenguva imwe chete muna 2019-2021 kwemavhiki mana akatevedzana, uye mamiriro ezvinhu emangwana achava akaoma zvikuru. Kubva pakati paChikumi, huwandu hwevanhu vane furuwenza hwakafanana nefuruwenza hwakataurwa muGuangzhou hwakawedzera ne10.38 kanodarika gore rapfuura.
Zvakabuda muongororo yekuongorora kwemhando yenyika gumi nerimwe yakaburitswa neThe Lancet Global Health muna Gumiguru zvakaratidza kuti mukana wekuti vanhu varipo vabatwe nefuruwenza wakawedzera kusvika pa60% zvichienzaniswa nedenda risati raitika. Zvakafanotaurawo kuti huwandu hwefuruwenza yemwaka we2022 huchawedzera nekamwe kusvika kashanu, uye huwandu hwedenda huchawedzera nekamwe kusvika kana kane.
Vanhu vakuru 212,466 vane hutachiona hweSARS-CoV-2 vakapinzwa muchipatara. Kuongororwa kwehutachiona hwekufema kwakanyorwa pavarwere 6,965 vane SARS-CoV-2. Kubatwa kwehutachiona hwehutachiona kwakaonekwa muvarwere 583 (8·4%): varwere 227 vaiva nemavhairasi efuruwenza, varwere 220 vaiva nehutachiona hwekufema hwesyncytial, uye varwere 136 vaiva nemavhairasi eadenovirus.
Kutapukirwa nehutachiona hwefuruwenza kwakabatana nekuwedzera kwemukana wekuwana mweya unofefetera unopinda mumuviri uchienzaniswa nehutachiona hweSARS-CoV-2. Kutapukirwa nehutachiona hwefuruwenza hweSARS-CoV-2 pamwe chete nemavhairasi efuruwenza uye mavhairasi e adenoviruses kwakabatana zvakanyanya nekuwedzera kwemukana wekufa. OR yekufema kwemuviri unofefetera muhutachiona hwefuruwenza hwaive 4.14 (95% CI 2.00-8.49, p=0.0001). OR yekufa muchipatara muvarwere vane furuwenza yaive 2.35 (95% CI 1.07-5.12, p=0.031). OR yekufa muchipatara muvarwere vane adenovirus pamwe chete yaive 1.6 (95% CI 1.03-2.44, p=0.033).
Zvakabuda muchidzidzo ichi zvinotiratidza pachena kuti kutapukirwa pamwe chete nehutachiona hweSARS-CoV-2 nehutachiona hwefuruwenza inyaya ine njodzi zvikuru.
Pamberi pekupararira kweSARS-CoV-2, zviratidzo zvemavhairasi akasiyana ekufema zvaive zvakafanana, asi nzira dzekurapa dzaive dzakasiyana. Kana varwere vasingashandisi bvunzo dzakawanda, kurapwa kwemavhairasi ekufema kuchave kwakaoma, uye zvichatambisa zviri nyore zviwanikwa zvechipatara munguva dzezviitiko zvakawanda. Saka, bvunzo dzakawanda dzemajoini dzinoita basa rakakosha mukuongororwa kwekiriniki, uye vanachiremba vanokwanisa kupa kuongororwa kwakasiyana kwezvirwere muvarwere vane zviratidzo zvekufema kuburikidza nesampuro imwe chete yeswab.
Mhinduro yeKuona Majoini Akawanda yeMacro & Micro-Test SARS-CoV-2 Respiratory Multiple Joint Detection Solution
Macro & Micro-Test ine mapuratifomu ehunyanzvi akadai se fluorescent quantitative PCR, isothermal amplification, immunication, uye molecular POCT, uye inopa mhando dzakasiyana dzezvigadzirwa zve SARS-CoV-2 respiratory joint detection. Zvigadzirwa zvese zvakawana chitupa cheEU CE, zvine mashandiro akanaka echigadzirwa uye ruzivo rwakanaka rwemushandisi.
1. Kiti yeRT-PCR ye fluorescent yenguva chaiyo yekuona mhando nhanhatu dzezvirwere zvekufema
Kudzora Kwemukati: Tarisa zvizere maitiro ekuyedza kuti uve nechokwadi chekuti kuyedza kwakanaka.
Kushanda Kwakanyanya: Multiplex real-time PCR inoona zvakasiyana-siyana zvakanangana neSARS-CoV-2, Furuwenza A, Furuwenza B, Adenovirus, Mycoplasma pneumoniae, uye Respiratory syncytial virus.
Kunzwa kwakanyanya: Makopi 300/mL eSARS-CoV-2, Makopi 500/mL evhairasi yefuruwenza A, Makopi 500/mL evhairasi yefuruwenza B, Makopi 500/mL evhairasi yekufema inopindirana nemhepo, Makopi 500/mL evairasi yemycoplasma pneumoniae, uye Makopi 500/mL evairasi yeadenovirus.
2. Kiti yekuona SARS-CoV-2/Furuwenza A/Furuwenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR)
Kudzora Kwemukati: Tarisa zvizere maitiro ekuyedza kuti uve nechokwadi chekuti kuyedza kwakanaka.
Kushanda Kwakanyanya: Multiplex real-time PCR inoona zvakasiyana-siyana zvakanangana neSARS-CoV-2, Furuwenza A neFuruwenza B.
Kunzwa kwakanyanya: Makopi mazana matatu/mL eSARS-CoV-2,500Makopi/mL e lFV A uye 500Makopi/mL e lFV B.
3. SARS-CoV-2, Furuwenza A uye Furuwenza B Antigen Detection Kit (Immunochromatography)
Zviri Nyore Kushandisa
Kutakurwa & Kuchengeterwa Zvinhu pa4-30°℃
Kunzwa kwakanyanya uye kujekesa
| Zita rechigadzirwa | Tsanangudzo |
| Kiti yeRT-PCR yeFluorescent yenguva chaiyo yekuona mhando nhanhatu dzehutachiona hwekufema | bvunzo makumi maviri pakiti,bvunzo makumi mana nemasere/kit,bvunzo makumi mashanu/kit |
| Kiti yekuona SARS-CoV-2/Furuwenza A/Furuwenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR) | bvunzo makumi mana nemasere/kit,bvunzo makumi mashanu/kit |
| SARS-CoV-2, Furuwenza A uye Furuwenza B Antigen Detection Kit (Immunochromatography) | 1 bvunzo/kit,bvunzo makumi maviri pakiti |
Nguva yekutumira: Zvita-09-2022